RGBP

distress 8/10 · high distress / dilution risk

$0.00+40%today-100% from 52w high

regenbiopharmainc.comFounded 2012La Mesa, CABiotechnology

Revenue

pre-revenue

Liquidity

$0M

Runway

0.1 yrs

Shares 1y

+374%

Price & events

-98.3% over 6M

CatalystRating changeDilutionFinancingdashed = today

+40.0%

-12.5%

-30.0%

-72.0%

-98.3%

-99.8%

-99.9%

-100.0%

All

Overview

Market Cap: $71.67K
Volume: 4.61M
52 Week Range: $0.00 – $0.09
Total Shares: 511.96M
Float Shares: 465.70M
% Held by Insiders: 9.92%
% Held by Institutions: 0.00%
RVOL: 0.11x
Beta: 0.23

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 511,957,643 · 0 offerings/1y · 0 PIPEs

none

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified